Dermsquared Dialogues - Update on Pathogenesis of Vitiligo

#top-leaderboard-ads, .stickyads { position: static !important; }

Update on Pathogenesis of Vitiligo

Featuring:

AAAndrew Alexis, MD, MPHClinical Advisory Boar…

Updated:Jun 29, 2023

1

Coordinating Care in the Transition to Mohs Surgery: Real-World Considerations for Dermatologists

16:35

Coordinating Care in the Transition to Mohs Surgery: Real-World Considerations for Dermatologists

2

When cSCC Gets Complex: A Multidisciplinary Approach for Dermatologists

10:17

When cSCC Gets Complex: A Multidisciplinary Approach for Dermatologists

3

Durability Matters in Atopic Dermatitis: Thinking Beyond Short-Term Response

7:39

Durability Matters in Atopic Dermatitis: Thinking Beyond Short-Term Response

4

Rethinking Hedgehog Inhibitors in Advanced Basal Cell Carcinoma: Sonedegib in Practice

14:46

Rethinking Hedgehog Inhibitors in Advanced Basal Cell Carcinoma: Sonedegib in Practice

5

Managing Partial Responders in Atopic Dermatitis: When to Optimize, Switch, or Combine Treatments

9:39

Managing Partial Responders in Atopic Dermatitis: When to Optimize, Switch, or Combine Treatments

6

Decoding the Bimekizumab SI/B Warning: What Dermatologists Should Know

9:59

Decoding the Bimekizumab SI/B Warning: What Dermatologists Should Know

7

Oral Therapies and the Future of Psoriasis Care

16:48

Oral Therapies and the Future of Psoriasis Care

8

The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis

12:44

The Itch Factor: Why Relief Can’t Wait in Atopic Dermatitis

9

From “Brown Bag Review” to Biologics: AD Care for 65+

13:19

From “Brown Bag Review” to Biologics: AD Care for 65+

10

Spotting the Systemic Candidate: Rethinking Treatment Goals in Atopic Dermatitis

13:57

Spotting the Systemic Candidate: Rethinking Treatment Goals in Atopic Dermatitis

11

The Axial Advantage: Expanding Psoriasis Care Across Indications

9:24

The Axial Advantage: Expanding Psoriasis Care Across Indications

12

Building Confidence with Hedgehog Inhibitors: Tips from the Clinic

18:08

Building Confidence with Hedgehog Inhibitors: Tips from the Clinic

13

Photodynamic Therapy in Actinic Keratosis: Evolving Approaches and Combination Strategies

13:31

Photodynamic Therapy in Actinic Keratosis: Evolving Approaches and Combination Strategies

14

Beyond the Skin: Addressing the Hidden Burden of Atopic Dermatitis

15:31

Beyond the Skin: Addressing the Hidden Burden of Atopic Dermatitis

15

From Skin to Joints: Clinical Impact of a Dual-Targeted Approach

7:27

From Skin to Joints: Clinical Impact of a Dual-Targeted Approach

16

Personalizing Atopic Dermatitis Care with JAK Inhibitors: Clinical Pearls for Real-World Practice

13:37

Personalizing Atopic Dermatitis Care with JAK Inhibitors: Clinical Pearls for Real-World Practice

17

High-Risk Cutaneous Squamous Cell Carcinoma: Refining Risk Stratification and Management

14:41

High-Risk Cutaneous Squamous Cell Carcinoma: Refining Risk Stratification and Management

18

Rapid Remission of Plaque Psoriasis With Bimekizumab: A Case Discussion

14:00

Rapid Remission of Plaque Psoriasis With Bimekizumab: A Case Discussion

19

Dupilumab in Practice: Navigating Use Across Clinical Scenarios

9:04

Dupilumab in Practice: Navigating Use Across Clinical Scenarios

20

Exploring a New Approach to Generalized Pustular Psoriasis

19:07

Exploring a New Approach to Generalized Pustular Psoriasis

21

Choosing an Oral Therapy: Deucravacitinib vs Apremilast

13:51

Choosing an Oral Therapy: Deucravacitinib vs Apremilast

22

Systemic Agents in Skin of Color

9:05

Systemic Agents in Skin of Color

23

The Oral Psoriasis Evolution: 5-Year Data on TYK2 Inhibition

15:21

The Oral Psoriasis Evolution: 5-Year Data on TYK2 Inhibition

24

Breaking the Cycle: A New Era in Atopic Dermatitis Care

13:40

Breaking the Cycle: A New Era in Atopic Dermatitis Care

25

GPP vs Plaque Psoriasis: Recognizing the Differences That Matter

11:45

GPP vs Plaque Psoriasis: Recognizing the Differences That Matter

26

More Than Skin Deep: Tackling Comorbidities in Atopic Dermatitis

9:31

More Than Skin Deep: Tackling Comorbidities in Atopic Dermatitis

27

GPP in Every Patient: Understanding Its Diverse Presentations for Better Treatment Outcomes

10:43

GPP in Every Patient: Understanding Its Diverse Presentations for Better Treatment Outcomes

28

Overcoming Barriers to Systemic Therapy in Atopic Dermatitis

16:37

Overcoming Barriers to Systemic Therapy in Atopic Dermatitis

29

Refining Sentinel Lymph Node Biopsy Decisions: The Role of GEP Testing in Melanoma Care

14:35

Refining Sentinel Lymph Node Biopsy Decisions: The Role of GEP Testing in Melanoma Care

30

Type 2 Inflammation in Skin Conditions: A Clinical Perspective

6:09

Type 2 Inflammation in Skin Conditions: A Clinical Perspective

31

Shifting the Paradigm: Chronic Management of Generalized Pustular Psoriasis

11:37

Shifting the Paradigm: Chronic Management of Generalized Pustular Psoriasis

32

Atopic Dermatitis Treatment in Skin of Color: Navigating Systemic Therapies and Addressing Unique Challenges

18:04

Atopic Dermatitis Treatment in Skin of Color: Navigating Systemic Therapies and Addressing Unique Challenges

33

Treating Atopic Dermatitis Early: Can We Impact the Atopic March?

16:28

Treating Atopic Dermatitis Early: Can We Impact the Atopic March?

34

Advances in Acne Treatment: 2024 Highlights and What to Watch for in 2025

3:29

Advances in Acne Treatment: 2024 Highlights and What to Watch for in 2025

35

Exploring Emerging Dermatology Devices and Treatments in 2025

12:10

Exploring Emerging Dermatology Devices and Treatments in 2025

36

Dermatologist's Guide to Winter Skin Care: Practical Tips to Share With Patients

5:14

Dermatologist's Guide to Winter Skin Care: Practical Tips to Share With Patients

37

Advances in Atopic Dermatitis: A 2024 Recap and 2025 Outlook

8:30

Advances in Atopic Dermatitis: A 2024 Recap and 2025 Outlook

38

Examining the Role of GLP-1 Receptor Agonists in Treating Inflammatory Skin Diseases

7:27

Examining the Role of GLP-1 Receptor Agonists in Treating Inflammatory Skin Diseases

39

National Healthy Skin Month: Maximizing Skin Health for Older Adults

1:58

National Healthy Skin Month: Maximizing Skin Health for Older Adults

40

National Healthy Skin Month: Expert Strategies for Optimizing Skin Health in Middle-Aged Adults

3:55

National Healthy Skin Month: Expert Strategies for Optimizing Skin Health in Middle-Aged Adults

41

National Healthy Skin Month: Managing Adolescent and Young Adult Patients

2:15

National Healthy Skin Month: Managing Adolescent and Young Adult Patients

42

Psoriasis and IL-17 Inhibitors: Balancing Efficacy and Safety with Ixekizumab

13:49

Psoriasis and IL-17 Inhibitors: Balancing Efficacy and Safety with Ixekizumab

43

National Healthy Skin Month: Supporting Healthy Skin in Babies

2:57

National Healthy Skin Month: Supporting Healthy Skin in Babies

44

Expanding Treatment Options for Actinic Keratosis: Tirbanibulin

7:35

Expanding Treatment Options for Actinic Keratosis: Tirbanibulin

45

Optimizing Long-Term Treatment of Moderate Atopic Dermatitis with Dupilumab

14:09

Optimizing Long-Term Treatment of Moderate Atopic Dermatitis with Dupilumab

46

The Role of Ixekizumab in Pediatric Psoriasis Management

10:46

The Role of Ixekizumab in Pediatric Psoriasis Management

47

The Role of the OX40/OX40 Ligand Pathway in Atopic Dermatitis

2:03

The Role of the OX40/OX40 Ligand Pathway in Atopic Dermatitis

48

World Mental Health Day: Dermatology's Role in Addressing Mental Health Impacts

2:16

World Mental Health Day: Dermatology's Role in Addressing Mental Health Impacts

49

Approaching Systemic Therapies for Moderate Atopic Dermatitis

14:27

Approaching Systemic Therapies for Moderate Atopic Dermatitis

50

Practical Guidance for Early-Career Dermatologists: Navigating Contracts and Career Choices

12:52

Practical Guidance for Early-Career Dermatologists: Navigating Contracts and Career Choices

51

Exploring the Role of Metformin in Treating CCCA

5:53

Exploring the Role of Metformin in Treating CCCA

52

Moderate Atopic Dermatitis: Treatment Considerations and Approaches

12:36

Moderate Atopic Dermatitis: Treatment Considerations and Approaches

53

Tips for Managing Hair Loss Disorders in Pediatric Patients

2:16

Tips for Managing Hair Loss Disorders in Pediatric Patients

54

Strategies to Address Disparities in Skin Cancer Outcomes

0:31

Strategies to Address Disparities in Skin Cancer Outcomes

55

Addressing Thyroid Concerns in Vitiligo: A Patient-Centered Perspective

0:39

Addressing Thyroid Concerns in Vitiligo: A Patient-Centered Perspective

56

Addressing Touch Starvation: Strategies for Improving Patient Well-Being

5:35

Addressing Touch Starvation: Strategies for Improving Patient Well-Being

57

Tackling Moderate Atopic Dermatitis: Treatment and Patient Care

12:43

Tackling Moderate Atopic Dermatitis: Treatment and Patient Care

58

Transforming Alopecia Areata: The Impact of JAK Inhibitors

11:47

Transforming Alopecia Areata: The Impact of JAK Inhibitors

59

Evaluating Benzene Concerns in Benzoyl Peroxide Products

3:19

Evaluating Benzene Concerns in Benzoyl Peroxide Products

60

New Perspectives on Chronic Pruritus

6:13

New Perspectives on Chronic Pruritus

61

Examining Benzene in Benzoyl Peroxide: Insights into the Latest Research

1:59

Examining Benzene in Benzoyl Peroxide: Insights into the Latest Research

62

Closing the Gap in GPP Treatment: Clinical Perspectives on Spesolimab

13:48

Closing the Gap in GPP Treatment: Clinical Perspectives on Spesolimab

63

Bridging the Gaps in Nail Disorder Management: New Approaches for Dermatologists

3:19

Bridging the Gaps in Nail Disorder Management: New Approaches for Dermatologists

64

Empowering Patients: Addressing the Psychological Impact of Vitiligo

1:42

Empowering Patients: Addressing the Psychological Impact of Vitiligo

65

Part 3: The Value of Support Groups in Vitiligo Care Beyond the Clinic

6:09

Part 3: The Value of Support Groups in Vitiligo Care Beyond the Clinic

66

Part 4: Practical Guidance on Navigating Support Groups

6:25

Part 4: Practical Guidance on Navigating Support Groups

67

Part 1: The Value of Vitiligo Support Groups for Patients and Providers

5:00

Part 1: The Value of Vitiligo Support Groups for Patients and Providers

68

Part 2: Integrating Mental Health Support in Vitiligo Support Groups

1:41

Part 2: Integrating Mental Health Support in Vitiligo Support Groups

69

Sunscreen MOAs: What Dermatologists and Patients Need to Know

1:04

Sunscreen MOAs: What Dermatologists and Patients Need to Know

70

Exploring a Triple-Combination Therapy for Acne Management

2:38

Exploring a Triple-Combination Therapy for Acne Management

71

Personalized Care in GPP: From Flares to Maintenance

10:16

Personalized Care in GPP: From Flares to Maintenance

72

Transformative Therapy for GPP: From Flares to Maintenance

7:46

Transformative Therapy for GPP: From Flares to Maintenance

73

Safety First: Addressing Sharps Injuries in Mohs Surgery

0:19

Safety First: Addressing Sharps Injuries in Mohs Surgery

74

Revisiting Superficial Radiation Therapy (SRT) as a Treatment Modality for Nonmelanoma Skin Cancer

0:29

Revisiting Superficial Radiation Therapy (SRT) as a Treatment Modality for Nonmelanoma Skin Cancer

75

Beyond the Flare: Understanding the Chronic Nature of GPP

3:31

Beyond the Flare: Understanding the Chronic Nature of GPP

76

Bright Spots: Tapinarof and the Evolving Nonsteroidal Landscape for Psoriasis

9:08

Bright Spots: Tapinarof and the Evolving Nonsteroidal Landscape for Psoriasis

77

Safety Alert: Essential Guidance for Dermatologists on Counterfeit Botox

1:12

Safety Alert: Essential Guidance for Dermatologists on Counterfeit Botox

78

Navigating Malignancy Risks in Atopic Dermatitis: Therapeutic Considerations

2:36

Navigating Malignancy Risks in Atopic Dermatitis: Therapeutic Considerations

79

Frontal Fibrosing Alopecia: A Clinical Pearl for Treating a Challenging Condition

3:54

Frontal Fibrosing Alopecia: A Clinical Pearl for Treating a Challenging Condition

80

Proactive Strategies: Counseling Patients on HS Flare Management

0:40

Proactive Strategies: Counseling Patients on HS Flare Management

81

Patient-Centered Care: Exam Tips for HS

0:31

Patient-Centered Care: Exam Tips for HS

82

Bright Spots: Exploring the Remittive Effect of Tapinarof for Plaque Psoriasis

11:07

Bright Spots: Exploring the Remittive Effect of Tapinarof for Plaque Psoriasis

83

Advancements in Vitiligo: 2024 and Beyond

0:42

Advancements in Vitiligo: 2024 and Beyond

84

Bright Spots: Tapinarof for Plaque Psoriasis of the Head and Neck

8:11

Bright Spots: Tapinarof for Plaque Psoriasis of the Head and Neck

85

Rare Diseases in Dermatology: Epidermolysis Bullosa

12:32

Rare Diseases in Dermatology: Epidermolysis Bullosa

86

Rare Diseases in Dermatology: New and Emerging Therapies

2:42

Rare Diseases in Dermatology: New and Emerging Therapies

87

Rare Diseases in Dermatology: Tuberous Sclerosis Complex

1:52

Rare Diseases in Dermatology: Tuberous Sclerosis Complex

88

Rare Diseases in Dermatology: SCLE and Dermatomyositis

1:12

Rare Diseases in Dermatology: SCLE and Dermatomyositis

89

PDT: A Noninvasive Approach to AK Management

1:25

PDT: A Noninvasive Approach to AK Management

90

Updated AAD Guidelines for Acne Vulgaris: A Summary of Key Points

3:22

Updated AAD Guidelines for Acne Vulgaris: A Summary of Key Points

91

Part 3—A Dermatologist’s Perspective: Updated Atopic Dermatitis Guidelines from the AAAAI/ACAAI Joint Task Force

2:52

Part 3—A Dermatologist’s Perspective: Updated Atopic Dermatitis Guidelines from the AAAAI/ACAAI Joint Task Force

92

Part 2—A Dermatologist’s Perspective: Updated Atopic Dermatitis Guidelines from the AAAAI/ACAAI Joint Task Force

4:00

Part 2—A Dermatologist’s Perspective: Updated Atopic Dermatitis Guidelines from the AAAAI/ACAAI Joint Task Force

93

Part 1—A Dermatologist’s Perspective: Updated Atopic Dermatitis Guidelines from the AAAAI/ACAAI Joint Task Force

3:30

Part 1—A Dermatologist’s Perspective: Updated Atopic Dermatitis Guidelines from the AAAAI/ACAAI Joint Task Force

94

Advancements in Skin Cancer Management: 2024 and Beyond

1:12

Advancements in Skin Cancer Management: 2024 and Beyond

95

Get Involved with Camp Discovery

2:37

Get Involved with Camp Discovery

96

Leprosy Unmasked: A Dermatologic Review for World Leprosy Day

7:00

Leprosy Unmasked: A Dermatologic Review for World Leprosy Day

97

Microneedling for patients with vitiligo: a promising option for repigmentation

4:33

Microneedling for patients with vitiligo: a promising option for repigmentation

98

Examining the Role of Optical Coherence Tomography in Diagnosing Recurrent Basal Cell Carcinoma

3:42

Examining the Role of Optical Coherence Tomography in Diagnosing Recurrent Basal Cell Carcinoma

99

Breaking Down the FDA-Mandated Changes to the iPLEDGE Program for Isotretinoin

2:58

Breaking Down the FDA-Mandated Changes to the iPLEDGE Program for Isotretinoin

100

The Role of Oxidants and Antioxidants in Vitiligo

4:14

The Role of Oxidants and Antioxidants in Vitiligo